 phase trial recombin human macrophag colony-stimul factor patient invas fungal infect phase escal trial recombin human macrophag colony-stimul factor rhm-csf combin convent antifung therapi marrow transplant recipi invas fungal infect daili dose toxic constitut symptom rhm-csf transient dose-rel thrombocytopenia patient rhm-csf mean reduct platelet count rhm-csf infus period signific patient dose rhm-csf patient rhm-csf allogen bone marrow transplant chang sever graft-versus-host diseas gvhd rhm-csf increas sever gvhd decreas effect neutrophil monocyt lymphocyt count patient resolut infect evalu respons patient day initi rhm-csf further trial rhm-csf antifung activ